Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitral valve annulus is a dynamic, D-shaped anatomical structure that serves as the junction between the left atrium and the left ventricle, providing the attachment site for the mitral valve leaflets [1]. It is a vital component of the heart's fibrous skeleton and plays a functional role during the cardiac cycle by contracting and folding to facilitate leaflet coaptation and reduce stress on the valve apparatus [2]. Pathological alterations, such as annular dilation or mitral annular calcification (MAC), are significant contributors to mitral regurgitation and stenosis, which can lead to progressive heart failure [3]. While the annulus is a primary target for surgical and transcatheter interventions—most notably through the use of annuloplasty rings—it is not a molecular target for pharmacological agents [1, 2]. Current clinical interest focuses on the imaging of the annulus for procedural planning and the management of associated valvular pathologies [3].
Not applicable as this is an anatomical structure rather than a molecular receptor; however, it is a target for mechanical intervention via annuloplasty devices.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitral valve annulus (MA).